1. Home
  2. THAR vs CREG Comparison

THAR vs CREG Comparison

Compare THAR & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • CREG
  • Stock Information
  • Founded
  • THAR 2017
  • CREG N/A
  • Country
  • THAR United States
  • CREG China
  • Employees
  • THAR N/A
  • CREG N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • CREG Power Generation
  • Sector
  • THAR Health Care
  • CREG Utilities
  • Exchange
  • THAR Nasdaq
  • CREG Nasdaq
  • Market Cap
  • THAR 5.5M
  • CREG 4.8M
  • IPO Year
  • THAR 2022
  • CREG N/A
  • Fundamental
  • Price
  • THAR $1.35
  • CREG $1.39
  • Analyst Decision
  • THAR Strong Buy
  • CREG
  • Analyst Count
  • THAR 1
  • CREG 0
  • Target Price
  • THAR $17.00
  • CREG N/A
  • AVG Volume (30 Days)
  • THAR 119.3K
  • CREG 4.5M
  • Earning Date
  • THAR 08-14-2025
  • CREG 08-14-2025
  • Dividend Yield
  • THAR N/A
  • CREG N/A
  • EPS Growth
  • THAR N/A
  • CREG N/A
  • EPS
  • THAR N/A
  • CREG N/A
  • Revenue
  • THAR N/A
  • CREG $82,839.00
  • Revenue This Year
  • THAR N/A
  • CREG N/A
  • Revenue Next Year
  • THAR N/A
  • CREG N/A
  • P/E Ratio
  • THAR N/A
  • CREG N/A
  • Revenue Growth
  • THAR N/A
  • CREG N/A
  • 52 Week Low
  • THAR $0.95
  • CREG $1.11
  • 52 Week High
  • THAR $6.39
  • CREG $14.70
  • Technical
  • Relative Strength Index (RSI)
  • THAR 46.35
  • CREG 36.08
  • Support Level
  • THAR $1.15
  • CREG $1.11
  • Resistance Level
  • THAR $1.66
  • CREG $1.68
  • Average True Range (ATR)
  • THAR 0.12
  • CREG 0.28
  • MACD
  • THAR 0.01
  • CREG 0.06
  • Stochastic Oscillator
  • THAR 39.22
  • CREG 18.67

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About CREG Smart Powerr Corp.

Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.

Share on Social Networks: